Epilepsy medication

The latest news and research on anti-epilepsy medication

Medicine shortages becoming ‘new normal’
Medicine shortages becoming ‘new normal’
Grace Wood | Epilepsy medicines Tegretol (carbamazepine) and Lamictal (lamotrigine) were among the medicines affected by shortages
Fix medicine supply chain or risk patients’ lives, warn charities
Fix medicine supply chain or risk patients’ lives, warn charities
Epilepsy Action joined with other charities to warn the government of ongoing issues with the medicine supply chain
Ketamine ‘effective’ for status epilepticus
Ketamine ‘effective’ for status epilepticus
Grace Wood | The researchers concluded it was “an effective drug with a good response rate”
EU introduces valproate measures
EU introduces valproate measures
Grace Wood | European Medicines Agency announces measures for prescribing valproate medicines
Drug developed for rare epilepsies
Drug developed for rare epilepsies
Grace Wood | Bexicaserin, an epilepsy drug for rare conditions, has been shown to reduce seizures
Sodium valproate restrictions to begin in January
Sodium valproate restrictions to begin in January
Grace Wood | New restrictions for sodium valproate come into effect on January 31, 2024. The changes affect men and boys for the first time
Valproate boxes must now contain safety warnings
Valproate boxes must now contain safety warnings
Grace Wood | Valproate will now be dispensed in the manufacturer’s original full packaging
Sanofi sells epilepsy medications to Pharmanovia
Sanofi sells epilepsy medications to Pharmanovia
Grace Wood | Pharmanovia is a global healthcare company with headquarters in Essex
EMA updates topiramate guidance
EMA updates topiramate guidance
Grace Wood | The measures have been put in place to avoid exposing children to topiramate-containing medicines in the womb
Page 1 of 5